The assessment of HER2 status in breast cancer: the past, the present, and the future - Nitta - 2016 - Pathology International - Wiley Online Library
Spotlight on Trastuzumab Deruxtecan for HER2-mutation NSCLC | LCTT
A novel treatment strategy for lapatinib resistance in a subset of HER2- amplified gastric cancer | BMC Cancer | Full Text
Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond - ScienceDirect
Cancers | Free Full-Text | HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies
Frontiers | HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies
Evolving novel anti-HER2 strategies - The Lancet Oncology
Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges - Cancer Treatment Reviews
HER2 Biomarker | Colorectal Cancer Alliance
Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer | Semantic Scholar
Frontiers | Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers
HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target | American Society of Clinical Oncology Educational Book
Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors | Scientific Reports
Cancers | Free Full-Text | Molecular Basis of HER2-Targeted Therapy for HER2-Positive Colorectal Cancer
In HER2 gene-amplified breast carcinoma cells primarily responsive to... | Download Scientific Diagram
HER2 signaling pathway, mechanism of action of targeted therapies, and... | Download Scientific Diagram
HER2 testing and its predictive utility in anti-HER2 breast cancer therapy | Biomarkers in Medicine
Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer | Oncotarget
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry | Cancer Cell International | Full Text
Signaling cascades activated by HER2 and mechanisms involved in their... | Download Scientific Diagram
Frontiers | HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives - ScienceDirect
Figure 2 from Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer | Semantic Scholar
HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now | npj Breast Cancer
